Join the Conversation!

You have made a big difference in my ability to live well. I haven't had treatment, but you are keeping me informed, and I don't feel alone.

~Patient Power survey respondent

Featured Programs

MPN News and Updates From ASCO 2017

As part of our coverage from the 2017 American Society of Clinical Oncology annual meeting, Dr. Srdan Verstovsek from The University of Texas MD Anderson Cancer Center provides a hopeful update for patients living with MPNs.


Making the Choice to Undergo Stem Cell Transplant for Myelofibrosis: A Patient Story

What factors should you consider when deciding to undergo a stem cell transplant (SCT) for myelofibrosis? Hear firsthand experience from Bo, who was diagnosed with an MPN at age 36.


The Current and Future Status of Pacritinib: An Expert Explains

Over the past year, the investigational oral kinase inhibitor, pacritinib, has been making headlines. To help patients sort through the information and to update us on the status of pacritinib, Dr. John Mascarenhas joined us from Mount Sinai Medical Center in New York City.


Join Our Community Register For Events Read Our Latest Blog

Page last updated on January 19, 2018